ALBRECHT JAMES W JR 4
4 · INTROGEN THERAPEUTICS INC · Filed Jan 11, 2006
Insider Transaction Report
Form 4
ALBRECHT JAMES W JR
Chief Executive Officer
Transactions
- Exercise/Conversion
stock option
2006-01-10−19,200→ 0 totalExercise: $0.39Exp: 2006-01-12→ common stock (19,200 underlying) - Exercise/Conversion
common stock
2006-01-10$0.39/sh+19,200$7,507→ 20,800 total
Footnotes (2)
- [F1]Right to buy.
- [F2]The option vested in four equal annual installments commencing 11/01/1995